Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function

被引:78
作者
Kreuger, J
Matsumoto, T
Vanwildemeersch, M
Sasaki, T
Timpl, R
Claesson-Welsh, L
Spillmann, D
Lindahl, U
机构
[1] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden
[2] Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[3] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
endostatin; heparan sulfate; heparin; oligosaccharides; sulfate groups;
D O I
10.1093/emboj/cdf638
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anti-angiogenic activity of endostatin (ES) depends on interactions with heparan sulfate (HS). In the present study, intact HS chains of greater than or equal to15 kDa bound quantitatively to ES whereas N-sulfated HS decasaccharides, with affinity for several fibroblast growth factor (FGF) species, failed to bind. Instead, ES-binding oligosaccharides composed of mixed N-sulfated and N-acetylated disaccharide units were isolated from pig intestinal HS. A 10/12mer ES-binding epitope was identified, with two N-sulfated regions separated by at least one N-acetylated glucosamine unit (SAS-domain). Cleavage at the N-acetylation site disrupted ES binding. These findings point to interaction between discontinuous sulfated domains in HS and arginine clusters at the ES surface. The inhibitory effect of ES on vascular endothelial growth factor-induced endothelial cell migration was blocked by the ES-binding SAS-domains and by heparin oligosaccharides (12mers) similar in length to the ES-binding SAS-domains, but not by timers capable of FGF binding. We propose that SAS-domains modulate the biological activities of ES and other protein ligands with extended HS-binding sites. The results provide a rational explanation for the preferential interaction of ES with certain HS proteoglycan species.
引用
收藏
页码:6303 / 6311
页数:9
相关论文
共 47 条
[1]   GLYCOSAMINOGLYCANS AND THE REGULATION OF BLOOD-COAGULATION [J].
BOURIN, MC ;
LINDAHL, U .
BIOCHEMICAL JOURNAL, 1993, 289 :313-330
[2]   Structure and biological interactions of heparin and heparan sulfate [J].
Casu, B ;
Lindahl, U .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 :159-206
[3]   Structure of a heparin-linked biologically active dimer of fibroblast growth factor [J].
DiGabriele, AD ;
Lax, I ;
Chen, DI ;
Svahn, CM ;
Jaye, M ;
Schlessinger, J ;
Hendrickson, WA .
NATURE, 1998, 393 (6687) :812-817
[4]   Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis [J].
Dixelius, J ;
Larsson, H ;
Sasaki, T ;
Holmqvist, K ;
Lu, LG ;
Engström, Å ;
Timpl, R ;
Welsh, M ;
Claesson-Welsh, L .
BLOOD, 2000, 95 (11) :3403-3411
[5]  
Dixelius J, 2002, CANCER RES, V62, P1944
[6]   Molecular diversity of heparan sulfate [J].
Esko, JD ;
Lindahl, U .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :169-173
[7]   Heparin structure and interactions with basic fibroblast growth factor [J].
Faham, S ;
Hileman, RE ;
Fromm, JR ;
Linhardt, RJ ;
Rees, DC .
SCIENCE, 1996, 271 (5252) :1116-1120
[8]   Age-dependent modulation of heparan sulfate structure and function [J].
Feyzi, E ;
Saldeen, T ;
Larsson, E ;
Lindahl, U ;
Salmivirta, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13395-13398
[9]   Heparan sulfate:: lessons from knockout mice [J].
Forsberg, E ;
Kjellén, L .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) :175-180
[10]   Heparan sulfate: growth control with a restricted sequence menu [J].
Gallagher, JT .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) :357-361